HBM Healthcare Investments (Cayman) Ltd. - Significant Ownership

Signature - Title
/s/ Jean-Marc LeSieur - Jean-Marc LeSieur, Managing Director
Location
Grand Cayman, Cayman Islands
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by HBM Healthcare Investments (Cayman) Ltd..

Significant Ownership of HBM Healthcare Investments (Cayman) Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALXO ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share 8.4% $2.21M $526K 4.5M +31.3% HBM Healthcare Investments (Cayman) Ltd. Mar 31, 2025
IOBT IO Biotech, Inc. Common Stock, par value $0.001 per share 8.2% $5.41M 5.52M HBM Healthcare Investments (Cayman) Ltd. Dec 31, 2023
IMRX Immuneering Corp Class A Common Stock, par value $0.001 per share 5.7% $29.7M 3.65M HBM Healthcare Investments (Cayman) Ltd. Sep 26, 2025
AVBP ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share 5.4% $40.5M 2.2M HBM Healthcare Investments (Cayman) Ltd. Oct 8, 2025
BNTC Benitec Biopharma Inc. Common Stock, par value $0.0001 per share 4.5% $13.6M 1.04M HBM Healthcare Investments (Cayman) Ltd. Dec 31, 2024
UPB Upstream Bio, Inc. Common Stock, par value $0.001 per share 4.1% $41.3M -$9.78M 2.2M -19.2% HBM Healthcare Investments (Cayman) Ltd. Sep 30, 2025
YMAB Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value 0% $0 0 HBM Healthcare Investments (Cayman) Ltd. Sep 30, 2025

Schedules 13D/G Reported by HBM Healthcare Investments (Cayman) Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.